PDX Pharmaceuticals in partnership with OHSU was among the four teams in Oregon that were awarded the 2022 Innovation in Philanthropy Award. The award recognizes PDX Pharma’s commitment (through donation and volunteer work at the BME of OHSU) in education and training in cancer research and nanotechnology. PDX Pharmaceuticals was also ranked among Oregon’s top ten most charitable small companies in 2022. The award ceremony was organized by the Portland Business Journal. PDX Pharmaceuticals, a preclinical stage biopharmaceutical company, firmly believes in supporting the next generation of biomedical scientists and innovators who will continue developing better therapeutics against difficult to treat cancer. Accepting the award were Dr. Wassana Yantasee, CEO of PDX Pharmaceuticals, and Dr. Owen McCarty, Chair of Biomedical Engineering of OHSU.